Individualized Medication Guidance for Cancer (800 Genes)

This test detects 800 genes related to targeted therapy, chemotherapy and endocrine drug, hereditary tumor, immunotherapy-related information (MSI and TMB), tumor core signaling pathway and tumor prognosis. The types of variants detected include SNV, InDel, amplifications and gene fusions, helping doctors formulate professional and individualized treatment plans for patients.

Features of Individualized Medication Guidance for Cancer (800 Genes)

Applicable Population of Individualized Medication Guidance for Cancer (800 Genes)

Patients with locally advanced or metastatic tumors looking for targeted drug therapy.

Patients with locally advanced or metastatic solid tumors and expecting immunotherapy, but no definitive driver genes been diagnosed.

Patients with locally advanced or metastatic solid tumors who are undergoing targeted therapy/immunotherapy, expecting dynamic monitoring of treatment through NGS.

Specification of Individualized Medication Guidance for Cancer (800 Genes)

Sample types Fresh tissue + venous blood / Paraffin specimen + venous blood / Venous blood

TAT 10 working days

As one of biotech companies genetic sequencing, we can provide professional genome sequencing service for clients, if you have needs, please contact us.